Title of article
Effect of abciximab on angiographic complications during percutaneous coronary stenting in the Evaluation of Platelet IIb/IIIa Inhibition in Stenting Trial (EPISTENT)
Author/Authors
Islam، نويسنده , , M.Ashequl and Blankenship، نويسنده , , James C and Balog، نويسنده , , Craig and Iliadis، نويسنده , , Elias A and Lincoff، نويسنده , , A.Michael and Tcheng، نويسنده , , James E and Califf، نويسنده , , Robert M and Topol، نويسنده , , Eric J، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2002
Pages
6
From page
916
To page
921
Abstract
In the Evaluation of Platelet IIb/IIIa Inhibition in Stenting Trial (EPISTENT), abciximab reduced ischemic complications of stent implantation at 30 days and 6 months. The responsible mechanisms remain unclear. We sought to determine if abciximab decrease
Journal title
American Journal of Cardiology
Serial Year
2002
Journal title
American Journal of Cardiology
Record number
1894740
Link To Document